|
V.V. Fomin
|
|
|
I.E. Chazova, V.V. Fomin
Management Of Cardiorenal Syndrome: Potentials For Use Of Angiotensin Ii Receptor Blockers
|
10-14 |
|
Yu.B. Belousov, S.K. Zyryanov, L.L. Shteynberg
Carbapenems (imipenem, Meropenem, Doripenem) In The Treatment Of Nosocomial Pneumonia: Current State Of The Problem
|
16-23 |
|
Samuels L.A.
Hyoscine Butylbromide In The Treatment Of Abdominal Spasms
|
24-29 |
|
D.A. Zateyshcikov, I.V. Zotova
Dabigatran: Prospects For Clinical Application
|
30-34 |
|
D.A. Napalkov, A.S. Panferov
Anemic Syndrome In Patients With Chronic Heart Failure
|
35-39 |
|
M.Yu. Gilyarov
Place Of Aspirin In The Therapy Of Atherothrombosis And Its Complications
|
40-43 |
|
G.A. Grigor’eva, N.Yu. Meshalkina
On The Problem Of Systemic Manifestations Of Inflammatory Bowel Diseases
|
44-49 |
|
N.A. Agafonova, E’.P. Yakovenko, A.N. Ivanov, A.V. Yakovenko, A.S. Pryanishnikova
Features Of Therapy Of Patients With Post-infectious Irritable Bowel Syndrome
|
50-55 |
|
S.V. Nikolaeva
Probiotic Products In Clinical Practice
|
56-57 |
|
L.A. Zvenigorodskaya, E.A. Cherkashova, N.G. Samsonova
Hepatoprotectors In The Treatment Of Nonalcoholic Fatty Liver Disease
|
58-63 |
|
L.I. Dvoretckiy’
Place Of Inhibitor-protected Penicillins In The Treatment Of Low Respiratory Tract Infections. Positions Remain Unchanged
|
64-68 |
|
V.V. Fomin
Place Of Cefixime In The Treatment Of Urinary Tract Infections
|
69-72 |
|
A.V. Gorelov, L.V. Feclisova, N.M. Grachyova, D.N. Alpenidze, Yu. N. Lin’kova, E.V. Chernyaeva, O.V. Salafet
Exogenous Interferonization As An Aspect Of Etiopathogenetic Treatment Of Acute Respiratory Viral Infections
|
73-81 |
|
T.E. Morozova, O.A. Vartanova
Potentials For Use Of Angiotensin-converting Enzyme Inhibitor Prestarium A In Correction Of Coronary And Myocardial Reserves In Patient With Coronary Heart Disease: Clinical Discussion
|
82-86 |
|
E.A. Belousova, M.N. Podlesscikh, O.M. Tcodikova
The Choice Of Laxatives: Place Of Stimulant Laxatives In The Treatment Of Constipation
|
87-92 |
|
O.V. Vorob’yova
Lumbar Spinal Pain Syndromes In Elderly Patients
|
94-98 |
|
I.A. Nesina, L.S. Egorova, A.A. Lyutkevich
Practical Experience Of Use Of Hepaguard® In Patients With Chronic Hepatitis
|
99-103 |
Русский
